Medicare Enrolled

Dr. Asit Choksi, MD

Medical Oncology · The Woodlands, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
9303 PINECROFT DR STE 280, The Woodlands, TX 77380
8328135259
In practice since 2006 (20 years)
NPI: 1295798874 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Choksi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choksi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Choksi

Dr. Asit Choksi is a medical oncology in The Woodlands, TX, with 20 years in practice. Based on federal Medicare data, Dr. Choksi performed 383,841 Medicare services across 1,396 unique beneficiaries.

Between the years covered by Open Payments, Dr. Choksi received a total of $5,239 from 5 pharmaceutical and/or device companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Choksi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 0% volume in TX$ $5,239 industry payments

Medicare Practice Summary

Medicare Utilization ↗
383,841
Medicare services
Top 0% in TX for medical oncology
1,396
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~19,192 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram148,620$1$2
Filgrastim injection (Zarxio) for white blood cells121,501$0$0
Nivolumab injection (Opdivo)59,680$21$66
Dexamethasone injection (steroid)10,614$0$0
Iron sucrose injection (Venofer)7,200$0$1
Denosumab injection (Prolia/Xgeva)6,900$17$52
Injection, granisetron hydrochloride, 100 mcg5,663$0$1
Injection, ipilimumab, 1 mg5,290$112$351
Epoetin alfa injection (Retacrit) for anemia4,360$6$21
Infusion, normal saline solution, 250 cc2,885$1$2
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less2,507$22$88
Blood draw (venipuncture)1,098$8$10
Drug injection, under skin or into muscle892$11$41
Office visit, established patient (20-29 min)764$66$240
Unclassified drugs753$7$37
Administration of chemotherapy into vein, 1 hour or less619$98$341
Injection, diphenhydramine hcl, up to 50 mg602$1$2
Injection, carboplatin, 50 mg535$2$6
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional503$17$59
Administration of chemotherapy into vein, each additional hour367$21$82
Infusion, normal saline solution, sterile (500 ml = 1 unit)353$1$3
Administration of additional new drug or substance into vein, 1 hour or less351$48$167
Office visit, established patient (30-39 min)299$96$363
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour286$16$53
Infusion into a vein for hydration, each additional hour270$10$35
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less242$48$192
Ceftriaxone antibiotic injection193$0$1
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle100$25$86
Infusion into a vein for hydration, 31-60 minutes95$23$84
Injection, ertapenem sodium, 500 mg94$11$45
Infusion, normal saline solution , 1000 cc64$2$6
Injection, methylprednisolone sodium succinate, up to 40 mg56$3$11
Drawing of blood for a medical problem32$70$250
New patient office visit (30-44 min)31$83$310
New patient office visit (45-59 min)22$127$420
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
97.3% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,239
Total received (2018-2024)
Avg $1,310/year across 4 years
Top 47% in TX for medical oncology
5
Companies
6
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,210 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$79
2021
$12
2020
$5,103
2018
$46

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$5,086
Celgene Corporation
$79
E.R. Squibb & Sons, L.L.C.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Acrotech Biopharma LLC
$12
Top 3 companies account for 99.3% of total payments
Associated products mentioned in payments ›
ALLODERM · BELEODAQ · JARDIANCE · OPDIVO · Revlimid
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a medical oncology in The Woodlands?
Compare medical oncologys in the The Woodlands area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
9
Per 100K population
1.4
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Choksi is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Choksi experienced with injection, filgrastim (g-csf), excludes biosimilars, 1 microgram?
Based on Medicare claims data, Dr. Choksi performed 148,620 injection, filgrastim (g-csf), excludes biosimilars, 1 microgram services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Choksi receive payments from pharmaceutical companies?
Yes. Dr. Choksi received a total of $5,239 from 5 companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choksi's costs compare to other medical oncologys in The Woodlands?
Dr. Choksi's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choksi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →